Entourage Health (CVE:ENTG) Reaches New 1-Year Low – Should You Sell?

Entourage Health Corp. (CVE:ENTGGet Free Report)’s share price reached a new 52-week low during mid-day trading on Monday . The company traded as low as C$0.01 and last traded at C$0.01, with a volume of 34719 shares traded. The stock had previously closed at C$0.01.

Entourage Health Stock Performance

The company has a 50 day moving average price of C$0.01 and a 200 day moving average price of C$0.01. The company has a debt-to-equity ratio of 2,914.72, a quick ratio of 0.91 and a current ratio of 0.10. The company has a market capitalization of C$3.08 million, a price-to-earnings ratio of -0.07 and a beta of 1.08.

About Entourage Health

(Get Free Report)

Entourage Health Corp. processes, produces, and distributes cannabis products for medical, adult-use, and bulk sales markets in Canada. It offers cannabis products, such as dried flower, pre-rolls, vapes, cannabis oils, topicals, soft chews, chewing gum, and micro inhalers. The company sells its products under the Color Cannabis, Saturday Cannabis, Starseed Medicinal, Dime Bag, Syndicate, Mary’s Medicinals, and Royal City Cannabis brand names.

Featured Stories

Receive News & Ratings for Entourage Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entourage Health and related companies with MarketBeat.com's FREE daily email newsletter.